The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...

Future Virology. 2008;3(2):179-192. Although not listed as a hemorrhagic fever virus, illness caused by CHIKV can be confused with diseases such as dengue or yellow fever, based on the similarity ...

Shares of French speciality vaccines developer Valneva (Nasdaq: VAL) were down 8.4% at 2.89 euros by early afternoon, after it announced a negative decision by France’s national public health agency.

1 The chikungunya virus (CHIKV), an alphavirus, is the causative agent of this serious illness. To facilitate viral RNA replication, CHIKV creates distinctive organelles called spherules on the ...

updated its recommendation for use of Valneva’s single-dose chikungunya vaccine IXCHIQ ® for the prevention of disease caused by the chikungunya virus (CHIKV). ACIP maintained its current ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Bavarian Nordic's ...

Now, in a recently released study of 117 children who were hospitalized between June and September 2024 (during the monsoon) ...

About chikungunyaChikungunya is a mosquito-borne disease caused by the chikungunya virus (CHIKV). In the past 20 years, the virus has emerged across several regions in Asia, Africa, and the ...

Chikungunya virus (CHIKV) is a mosquito-borne viral disease spread by the bites of infected Aedes mosquitoes which causes fever, severe joint and muscle pain, headache, nausea, fatigue and rash. Joint ...

About VIMKUNYA® Chikungunya vaccine (recombinant, adsorbed) VIMKUNYA is a single dose, prefilled, adjuvanted VLP recombinant protein vaccine for active immunization for the prevention of disease ...